Thailand’s Food and Drug Administration (FDA) has issued a public alert after laboratory tests found that a batch of the popular Hong Thai Herbal Inhaler, Formula 2, had failed to meet safety standards due to microbial contamination.
According to an X post by Thai Enquirer, tests conducted by the country’s Department of Medical Sciences revealed that the products, under the batch number 000332, exceeded acceptable limits for Total Aerobic Microbial Count, Total Combined Yeasts and Mould Count and Clostridium spp. contamination.
A batch of the popular Hong Thai Herbal Inhaler was found to be contaminatedĀ
The affected batch, 000332, has the manufacturing date of 9 December 2024 and an expiry date of 8 December 2027.
The FDA has since warned the general public against purchasing and consuming the product under the mentioned batch number due to it being substandard under Section 60 (2) of the Herbal Product Act B.E. 2562 (2019).
Thai authorities consider legal action against the manufacturer
The Thai authorities also shared that they are considering legal proceedings against the manufacturer.
Should they pursue legal action, the manufacturer can face up to 2 years in prison and a fine of up to THB200,000 (~RM25,800), while those selling the affected batch can face up to 6 months in prison and a fine of up to THB50,000 (~RM6,400).
What do you think about this? Do feel free to share your thoughts in the comment section.
Also read: China Now Requires Influencers to Have Professional Certs to Discuss Medicine, Law, Finance & More
